In a historic agreement that symbolizes the increasingly rapid convergence between artificial intelligence and biotech, NVIDIA Corporation and Eli Lilly & Company announced the...
insitro, the AI therapeutics company built on causal biology, announced that it has entered into a definitive agreement to acquire CombinAbleAI and launch its...
Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering
Revvity, Inc. announced a collaboration with Eli Lilly and Company (Lilly) that...
Collaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster-from strategy to measurable outcomes.
L7 Informatics, and Turnberry...
Recognized neonatologist and payer-strategy leader joins GeneDx to expand earlier diagnosis and establish genomics as a standard of care across healthcare
GeneDx has officially appointed Dr....
In its third major move in six months, Matrix One (backed by Lauxera Capital Partners) has acquired Simploud, a cloud-native provider of Quality Management...
Fresh off its landmark December 2025 listing on the Hong Kong Stock Exchange, Insilico Medicine has inked a multi-year R&D collaboration with global pharma...